Product information
From Health Canada
No match found
No other product was found with the same active ingredient group.
The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.
Current status:
Cancelled Post Market
Current status date:
2008-12-08
Original market date: See footnote 1
1999-06-22
Product name:
CIPRO HC OTIC SUSPENSION
DIN:
02240035
Product Monograph/Veterinary Labelling:
Date:
1999-05-12
Product monograph/Veterinary Labelling (PDF version ~ 175K)
Company:
ALCON CANADA INC
2665 Meadowpine Blvd
Mississauga
Ontario
Canada
L5N 8C7
Class:
Human
Dosage form(s):
Suspension
Route(s) of administration:
Otic
Number of active ingredient(s):
2
Schedule(s):
Prescription
American Hospital Formulary Service (AHFS): See footnote 3
52:04.04 , 52:08.08
Anatomical Therapeutic Chemical (ATC): See footnote 4
S02CA03 HYDROCORTISONE AND ANTIINFECTIVES
Active ingredient group (AIG) number:See footnote5
0237145001
| Active ingredient(s) See footnote8 | Strength |
|---|---|
| CIPROFLOXACIN (CIPROFLOXACIN HYDROCHLORIDE) | 2 MG / ML |
| HYDROCORTISONE | 10 MG / ML |